학술논문
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
Document Type
Article
Author
Al Malki, M.M.; Nakamura, R.; London, K.; Baez, J.; Akahoshi, Y.; Etra, A.; Capellini, A.; Eng, G.; Gandhi, I.; Kasikis, S.; Kowalyk, S.; Morales, G.; Spyrou, N.; Young, R.; Ferrara, J.L.M.; Levine, J.E.; Hogan, W.J.; Choe, H.; Hexner, E.; Langston, A.; Abhyankar, S.; Ponce, D.M.; DeFilipp, Z.; Chen, Y.-B.; Kitko, C.L.; Adekola, K.; Reshef, R.; Ayuk, F.; Chanswangphuwana, C.; Eder, M.; Grupp, S.; Gleich, S.; Holler, E.; Javorniczky, N.R.; Özbek, U.; Rösler, W.; Yanik, G.
Source
In: Blood Advances . (Blood Advances, 12 September 2023, 7(17):5189-5198)
Subject
Language
English
ISSN
24739537
24739529
24739529